Millar-Craig M W, Mann S, Balasubramanian V, Cashman P, Raftery E B
J Cardiovasc Pharmacol. 1981 May-Jun;3(3):468-76. doi: 10.1097/00005344-198105000-00006.
The intra-arterial blood pressure of 20 male patients with essential hypertension was continuously recorded during dynamic exercise. Graded exercise testing on a bicycle ergometer and a stair-climbing test were performed prior to and during treatment with oxprenolol. Acute oxprenolol therapy was associated with a reduction in heart rate but little reduction in blood pressure. Chronic treatment for 14.3 weeks with oxprenolol (mean daily dose, 344 mg) was associated with a substantial reduction of blood pressure at rest and at each level of bicycle exercise. A similar antihypertensive effect was demonstrated during stair climbing. The normal blood pressure response to exercise as assessed by the relative (percentage) increase in pressure above the pre-exercise level and the rate of increase in blood pressure (per unit of work), as well as exercise tolerance, were unchanged by chronic beta-blockade with oxprenolol.
在动态运动过程中,对20例原发性高血压男性患者的动脉内血压进行了连续记录。在使用氧烯洛尔治疗之前和治疗期间,进行了自行车测力计分级运动试验和爬楼梯试验。急性氧烯洛尔治疗与心率降低有关,但血压降低幅度较小。用氧烯洛尔进行14.3周的慢性治疗(平均每日剂量344毫克)与静息时以及自行车运动各水平时的血压大幅降低有关。爬楼梯时也显示出类似的降压效果。通过运动前水平以上压力的相对(百分比)增加以及血压升高速率(每单位工作量)评估的正常运动血压反应,以及运动耐力,在使用氧烯洛尔进行慢性β受体阻滞剂治疗后未发生改变。